ShareHope Medicine Co., Ltd. (TPEX:8403)
19.25
-0.10 (-0.52%)
Aug 19, 2026, 10:19 AM CST
ShareHope Medicine Revenue
ShareHope Medicine had revenue of 1.19B TWD in the quarter ending June 30, 2026, with 10.52% growth. This brings the company's revenue in the last twelve months to 4.50B, up 2.52% year-over-year. In the year 2025, ShareHope Medicine had annual revenue of 4.36B with 0.74% growth.
Revenue (ttm)
4.50B
Revenue Growth
+2.52%
P/S Ratio
0.61
Revenue / Employee
37.15M
Employees
118
Market Cap
2.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.36B | 32.04M | 0.74% |
| Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
| Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
| Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
| Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Qing Song Health | 1.21B |
| Chunghwa Chemical Synthesis & Biotech | 934.29M |
| A Plus Biotechnology | 887.93M |
| GlycoNex Incorporation | 36.35M |
| Caliway Biopharmaceuticals | 29.39M |
| Pell Bio-Med Technology | 28.93M |
| BRIM Biotechnology | 10.60M |